Evidence map›Paper›PMID 34884778›Full record

ReviewInternational journal of molecular sciences2021

Exploiting Structural Modelling Tools to Explore Host-Translocated Effector Proteins.

Sahel Amoozadeh, Jodie Johnston, Claudia-Nicole Meisrimler

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Identification of the Major Effector StSROs in Potato: A PotentialInternational journal of molecular sciences · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sahel AmoozadehSchool of Biological Science, University of Canterbury, Christchurch 8041, New Zealand.ORCID 0000-0002-4972-8479
Jodie JohnstonSchool of Physical and Chemical Sciences, University of Canterbury, Christchurch 8041, New Zealand.
Claudia-Nicole MeisrimlerSchool of Biological Science, University of Canterbury, Christchurch 8041, New Zealand.

Funding

New Zealand Tertiary Education Commission CoRE Bioprotection AoteroaUniversity of Canterbury PhD Scholarship
6 · The paper itself

Abstract

Oomycete and fungal interactions with plants can be neutral, symbiotic or pathogenic with different impact on plant health and fitness. Both fungi and oomycetes can generate so-called effector proteins in order to successfully colonize the host plant. These proteins modify stress pathways, developmental processes and the innate immune system to the microbes' benefit, with a very different outcome for the plant. Investigating the biological and functional roles of effectors during plant-microbe interactions are accessible through bioinformatics and experimental approaches. The next generation protein modeling software RoseTTafold and AlphaFold2 have made significant progress in defining the 3D-structure of proteins by utilizing novel machine-learning algorithms using amino acid sequences as their only input. As these two methods rely on super computers, Google Colabfold alternatives have received significant attention, making the approaches more accessible to users. Here, we focus on current structural biology, sequence motif and domain knowledge of effector proteins from filamentous microbes and discuss the broader use of novel modelling strategies, namely AlphaFold2 and RoseTTafold, in the field of effector biology. Finally, we compare the original programs and their Colab versions to assess current strengths, ease of access, limitations and future applications.

Indexed as

Fungal ProteinsFungiHost-Pathogen InteractionsMolecular ConformationOomycetesPlant DiseasesPlantsSymbiosisFungal ProteinsAlphaFold2effector proteinsfungioomycetesprotein modellingRoseTTafold

Identifiers

PMID34884778
PMCPMC8657640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.